rss icon

Six months into his tenure, Perrigo Co. plc CEO Uwe Röhrhoff is focused on accelerating growth. 

Published in Manufacturing

ALLEGAN — John Hendrickson says the decision to retire as CEO of Perrigo Co. plc was personal and his choice alone.

Published in Manufacturing

Problems with operations in Europe drove Perrigo Co. plc to a loss in the first quarter amid higher sales.

Published in In the News

ALLEGAN — John Hendrickson assumed command at Perrigo Co. plc as the company faces problems in Europe that will cut into 2016 earnings.

Published in In the News

ALLEGAN — Fighting off a hostile takeover bid cost Perrigo Co. plc $100 million last year, driving up administrative expenses sharply for the producer of over-the-counter medications.

Published in Economic Development

Perrigo Co. plc (NYSE: PRGO) lost money during the fourth quarter of 2015, the result of problems in its Branded Consumer Healthcare division.

Published in In the News

As it tries to fend off a hostile takeover bid by Mylan N.V., Perrigo Co. plc intends to push ahead with a growth strategy based on new product development and acquisitions.

Published in Health Biz

ALLEGAN — Growth in the second quarter provides an example of why Chairman and CEO Joe Papa sees a bright future for Perrigo Co. plc and why directors have rejected overtures from Mylan N.V. in the lead up to a hostile takeover attempt.

Published in Manufacturing

Directors at Perrigo Co. plc have rejected a buyout offer from English-based Mylan N.V. citing its own strong growth potential through new product development and from business related to past and future acquisitions.

Published in In the News

Perrigo Co. plc’s latest big acquisition closes March 30, significantly expanding the company’s European base.

Published in In the News
Page 1 of 2

Breaking News

September 2018
S M T W T F S
26 27 28 29 30 31 1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 1 2 3 4 5 6

Follow MiBiz